» Articles » PMID: 16930162

Substance Use Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and International Classification of Diseases, Tenth Edition (ICD-10)

Overview
Journal Addiction
Specialty Psychiatry
Date 2006 Aug 26
PMID 16930162
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Two major nomenclatures, Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10), currently define substance use disorders for broad audiences of users with different training, experience and interests. A comparison of these definitions and their implications for DSM-V and ICD-11 has not been available.

Methods: The background for the dependence concept and abuse, harmful use, withdrawal, substance-induced disorders and remission and other substance-related conditions is reviewed. Reliability evidence is presented, as is validity evidence from approaches including psychometric, genetic and animal studies. The relevance of the DSM-IV and ICD-10 compared to alternative systems (e.g. the Addiction Severity Index) is considered.

Results: Reliability and psychometric validity evidence for substance dependence is consistently strong, but more mixed for abuse and harmful use. Findings on the genetics of alcohol disorders support the validity of the dependence concept, while animal studies underscore the centrality of continued use despite negative consequences to the concept of dependence. While few studies on substance-induced disorders have been conducted, those published show good reliability and validity when elements of DSM-IV and ICD-10 are combined.

Conclusions: Dependence in DSM-V and ICD-11 should be retained, standardizing both criteria sets and adding a severity measure. The consequences of heavy use should be measured independently of dependence; add cannabis withdrawal if further research supports existing evidence; conduct further studies of the substance-induced psychiatric categories; standardize their criteria across DSM-V and ICD-11; develop a theoretical basis for better remission criteria; consider changing substance 'abuse' to substance 'dysfunction disorder'; and conduct clinician education on the value of the diagnostic criteria.

Citing Articles

Chinese herbal medicines for the treatment of depression: a systematic review and network meta-analysis.

Dang C, Wang Q, Li Q, Xiong Y, Lu Y Front Pharmacol. 2024; 15:1295564.

PMID: 38633609 PMC: 11021639. DOI: 10.3389/fphar.2024.1295564.


Effectiveness of the Apple Watch as a mental health tracker.

Adil M, Atiq I, Younus S J Glob Health. 2024; 14:03010.

PMID: 38332682 PMC: 10853680. DOI: 10.7189/jogh.14.03010.


miRNA cargo in circulating vesicles from neurons is altered in individuals with schizophrenia and associated with severe disease.

Barnett M, Reay W, Geaghan M, Kiltschewskij D, Green M, Weidenhofer J Sci Adv. 2023; 9(48):eadi4386.

PMID: 38019909 PMC: 10686555. DOI: 10.1126/sciadv.adi4386.


Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder.

Requena-Ocana N, Flores-Lopez M, Garcia-Marchena N, Pavon-Moron F, Pedraza C, Wallace A Int J Mol Sci. 2023; 24(21).

PMID: 37958570 PMC: 10649657. DOI: 10.3390/ijms242115586.


Substance Use Disorders, Mental Illness, and Health Care Utilization Among Adults With Recent Criminal Legal Involvement.

Shah H, Hawks L, Walker R, Egede L Psychiatr Serv. 2023; 75(3):221-227.

PMID: 37674397 PMC: 11451170. DOI: 10.1176/appi.ps.20220491.